skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Elucidation of the Specific Function of the Conserved Threonine Triad Responsible for Human L-Asparaginase Autocleavage and Substrate Hydrolysis

Authors:
; ;  [1]
  1. UIC
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
UNIVERSITYNIH
OSTI Identifier:
1252738
Resource Type:
Journal Article
Resource Relation:
Journal Name: Journal of Molecular Biology; Journal Volume: 426; Journal Issue: (13) ; 06, 2014
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Nomme, Julian, Su, Ying, and Lavie, Arnon. Elucidation of the Specific Function of the Conserved Threonine Triad Responsible for Human L-Asparaginase Autocleavage and Substrate Hydrolysis. United States: N. p., 2016. Web. doi:10.1016/j.jmb.2014.04.016.
Nomme, Julian, Su, Ying, & Lavie, Arnon. Elucidation of the Specific Function of the Conserved Threonine Triad Responsible for Human L-Asparaginase Autocleavage and Substrate Hydrolysis. United States. doi:10.1016/j.jmb.2014.04.016.
Nomme, Julian, Su, Ying, and Lavie, Arnon. 2016. "Elucidation of the Specific Function of the Conserved Threonine Triad Responsible for Human L-Asparaginase Autocleavage and Substrate Hydrolysis". United States. doi:10.1016/j.jmb.2014.04.016.
@article{osti_1252738,
title = {Elucidation of the Specific Function of the Conserved Threonine Triad Responsible for Human L-Asparaginase Autocleavage and Substrate Hydrolysis},
author = {Nomme, Julian and Su, Ying and Lavie, Arnon},
abstractNote = {},
doi = {10.1016/j.jmb.2014.04.016},
journal = {Journal of Molecular Biology},
number = (13) ; 06, 2014,
volume = 426,
place = {United States},
year = 2016,
month = 7
}
  • Allelic loss studies have suggested that a glioma tumor suppressor gene resides in a 425-kb region of chromosome 19q, telomeric to D19S219 and centromeric to D19S112. Exon amplification of a cosmid contig spanning this region yielded for exons with high homology to a rat protein serine-threonine phosphate from a cosmid approximately 100 kb telomeric to D19S219. Isolation of a near full-length cDNA from a human fetal brain cDNA library revealed a protein serine-threonine phosphate with a tetratricopeptide motif, almost identical to human PPP5C (PP5) and highly homologous to rat PPT. Northern blotting demonstrated expression in most human tissues, including brain.more » Primary and cultured gliomas were studied for genetic alterations in this gene using pulsed-field gel electrophoresis, routine Southern blots, and genomic DNA and RNA-based single strand conformation polymorphism analysis. Genomic alterations were not detected in any of the gliomas, and all studied gliomas expressed the gene, suggesting that this phosphatase is not the putative chromosome 19q glioma tumor supressor gene. 19 refs., 2 figs.« less
  • Human myocyte-specific enhancer binding factor 2C (hMEF2C) belongs to the MEF2 subfamily of the MADS (MCM1, AGAMOUS, DEF A, serum response factor) family of transcription factors. Members of the MADS family share a conserved domain - the MADS domain - that is necessary for DNA binding. Highly conserved versions of the MADS domain and of an adjacent domain that is known as the MEF2 domain are found in members of the MEF2 subfamily. Both of these domains are necessary for binding to the MEF2 regulatory element. This regulatory element is known to be functionally important in a variety of muscle-specificmore » genes and possibly in the brain creatine kinase gene. The MEF2C gene product activates transcription by binding to the MEF2 element. hMEF2C is expressed at high levels in postmitotic neurons in the brain, where it is most abundant in the cerebral cortex, and is also expressed in differentiated myotubes. Several lines of evidence suggest the existence of a rat homologue of MEF2C, and a mouse homologue has been cloned. The mouse gene was mapped to mouse chromosome 13 in a region that is syntenic to human 5q13-q15. 12 refs., 1 fig.« less
  • We have previously shown that human leukemic cells proliferate normally in serum-free media containing various transferrin forms, but the addition of transferrin-gallium leads to inhibition of cellular proliferation. Because gallium has therapeutic potential, the effects of transferrin-gallium on leukemic cell proliferation, transferrin receptor expression, and cellular iron utilization were studied. The cytotoxicity of gallium is considerably enhanced by its binding to transferrin and cytotoxicity can be reversed by transferrin-iron but not by other transferrin forms. Exposure to transferrin-gallium leads to a marked increase in cell surface transferrin binding sites, but despite this, cellular /sup 59/Fe incorporation is inappropriately low. Althoughmore » shunting of transferrin-gallium to another cellular compartment has not been ruled out, other studies suggest that transferrin-gallium impairs intracellular release of /sup 59/Fe from transferrin by interfering with processes responsible for intracellular acidification. These studies, taken together, demonstrate that inhibition of cellular iron incorporation by transferrin-gallium is a prerequisite for inhibition of cellular proliferation.« less
  • For a better understanding of genes that potentially function in B lymphocyte cell signaling, the authors isolated the human genomic counterpart of the murine pp52 or LSP1 gene. They unexpectedly found that the human pp52 gene is one of four closely related loci. Representative cosmids from each of the four family members were isolated and chromosomally localized by fluorescence in situ hybridization. Nucleotide sequence was obtained from an exon common to each locus and demonstrated very close similarity among all four loci. Two of the four loci harbored dysfunctional frameshift mutations or premature translation stop sites. The exon of onemore » locus was flanked by an 80-bp perfect inverted repeat, suggesting that it may have originated through a looped intermediate DNA structure. Through a series of cDNA hybridization studies and nucleotide sequence analyses the authors were able to unambiguously link the lymphocyte-expressed gene to the locus mapped to chromosome 11p15.5. This same chromosomal band has been involved in tumor-related chromosomal translocations found in chronic lymphocytic leukemia. 21 refs., 4 figs.« less
  • All class II major histocompatibility complex genes contain two highly conserved sequences, termed X and Y, with the promoter region(s), which may have a role in regulation of expression. To study trans-acting factors that interact with these sequences, sequence-specific DNA binding activity has been examined by the gel electrophoresis retardation assay using the HLA-DQ2..beta.. gene 5' flanking DNA and nuclear extracts derived from various cell types. Several specific protein-binding activities were found using a 45-base-pair (bp) HinfI/Sau96I (-142 to -98 bp) and a 38-bp Sau96I/Sau96I (-97 to -60 bp) fragment, which include conserved sequence X (-113 to -100 bp) andmore » conserved sequence Y (-80 to -71 bp), respectively. Competition experiments, methylation interference analysis, and DNase I footprinting demonstrated that distinct proteins in a nuclear extract of Raji cells (a human B lymphoma line) bind to sequence X, to sequence Y, and to DNA 5' of the X sequence (termed sequence W). The factor binding site in the W sequence is also found to be conserved among ..beta..-chain genes and is suggested to be a ..gamma..-interferon control region.« less